Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Explore effective ways to utilize your credit card points. Unlock their full value with smart redemption strategies.
14,952 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
A sudden geopolitical flare pushes crypto and traditional markets lower. This morning minute: markets tumble, testing...
Rising medical costs are pushing families to cut meals and delay care, reshaping budgets and investment strategies am...
United Airlines will cut about 5% of capacity this quarter as jet fuel prices climb amid geopolitical tensions. The m...
A single viral moment can ripple through markets and your wallet. This guide explains how media buzz affects money de...
Tesla posts stronger margins amid a delivery dip, while Rivian turns profitable on software and a hopeful R2 ramp. An...
Circle Internet Group stock took a sharp drop as headlines pointed to potential US regulation that could curb stablec...
The U.S. Postal Service will apply a temporary fuel surcharge to certain postage rates as fuel costs rise, a move aim...
When fear takes the wheel, investors often forget the basics. This guide lays out three practical reminders to stay t...
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
A durable capex cycle is forming around upgrading the power grid to handle AI, EV charging, and reshoring needs. Anal...
Dine Brands (DIN) 2026 presents a pivotal earnings outlook with evolving margins, franchise dynamics, and a path to g...